26.47% | % of shares held by all insiders |
27.30% | % of shares held by institutions |
37.13% | % of float held by institutions |
100 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Softbank Group Corporation | 5,681,818 | 31 Dec 2023 | 4.70% | 26,704,543 |
Laurion Capital Management, LP | 5,409,533 | 31 Dec 2023 | 4.47% | 25,424,804 |
Baillie Gifford and Company | 4,574,405 | 31 Mar 2024 | 3.78% | 21,499,702 |
Platinum Investment Management Ltd | 4,088,318 | 31 Dec 2023 | 3.38% | 19,215,093 |
Woodline Partners LP | 1,642,942 | 31 Dec 2023 | 1.36% | 7,721,827 |
Bill & Melinda Gates Foundation | 1,590,909 | 31 Dec 2023 | 1.32% | 7,477,271 |
MIC Capital Management UK LLP | 1,542,600 | 31 Dec 2023 | 1.28% | 7,250,219 |
Marshall Wace LLP | 1,300,068 | 31 Dec 2023 | 1.08% | 6,110,319 |
Nan Fung Group Holdings Limited | 859,892 | 31 Dec 2023 | 0.71% | 4,041,492 |
Pivotal bioVenture Partners Investment Advisor, LLC | 770,500 | 31 Dec 2023 | 0.64% | 3,621,349 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
iShares Biotechnology ETF | 727,272 | 31 Mar 2024 | 0.60% | 3,418,178 |
WisdomTree Tr-WisdomTree Artificial Intelligence & Innovation Fd | 185,301 | 29 Feb 2024 | 0.15% | 870,914 |
Goldman Sachs ETF Tr-Goldman Sachs Innovate Equity ETF | 39,582 | 31 Mar 2024 | 0.03% | 186,035 |
ETF Series Solutions-Range Cancer Therapeutics ETF | 32,092 | 29 Feb 2024 | 0.03% | 150,832 |
Baillie Gifford Health Innovation Equities Fund | 25,810 | 31 Dec 2023 | 0.02% | 121,306 |
Fidelity NASDAQ Composite Index Fund | 26,738 | 29 Feb 2024 | 0.02% | 125,668 |
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 24,648 | 29 Feb 2024 | 0.02% | 115,845 |
Themes ETF Tr-Themes Generative Artificial Intelligence ETF | 13,641 | 31 Dec 2023 | 0.01% | 64,112 |
ETFis Ser Tr I-Virtus LifeSci Biotech Clinical Trials ETF | 13,909 | 31 Jan 2024 | 0.01% | 65,372 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 3,523 | 31 Mar 2024 | 0.00% | 16,558 |